The European Science Journalist of the Year Award celebrates excellence and innovation in science journalism, and is open to members of science writing associations across Europe, as well as those whose work has been published in European media.

With a first prize of 1000 Euro, and 500 Euro each for the second and third-place winners, this award truly recognises those journalists who are writing scientific stories on issues that matter to the general public. The writing could cover anything from a global pandemic to artificial intelligence, to science in a war zone.

Our judges want to take a deep dive into work written and published in European media, so they ask for three pieces from each nomination. They are looking for variety and range, both by topic and method of reporting, if possible.

The award is supported by Elsevier, the global information and analytics provider. Michiel Kolman, Senior Vice President, Research Networks at Elsevier said “In this age of misinformation, there has never been a more important time to celebrate excellence in science journalism. Elsevier is proud to support these awards as we seek to maintain and build confidence in science and research among all audiences, from public to policy makers, and we look forward to hearing from the talented journalists these awards will no doubt highlight.”

For further guidance on eligibility and rules, please refer to the Award Policy and Guidelines.

Deadline for submissions: 1 June 2023, 23:59 CET.

Enter via email to

About European Federation for Science Journalism

The European Federation for Science Journalism is a non-profit organisation that aims to promote independent, high-quality science journalism across Europe by organising meetings and conferences, setting-up cross-border investigative reporting grants, and running awards. The EFSJ supports and stimulates journalists to critically examine, challenge and assess scientific information in a social, cultural, political, ethical and economic context. The EFSJ also aims to help develop and support new business models for independent science journalism and stimulate the debate about the role of science journalism and science communication.

About Elsevier
As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems. In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions and funders.

Elsevier employs 8,700 people worldwide. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirectScopusSciValClinicalKey and Sherpath support strategic research managementR&D performanceclinical decision support, and health education. Researchers and healthcare professionals rely on our over 2,700 digitized journals, including The Lancet and Cell; our over 43,000 eBook titles; and our iconic reference works, such as Gray’s Anatomy. With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.

Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.